Skip to content

Hancock Modified Orifice Bioprosthesis

by Medtronic Heart Valves

PMA P790007

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

PMA P790007↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved 1 supplement NumberP790007 Date30 May 1985ApprovedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Generic Name
heart-valve, non-allograft tissue
PMA Number
FDA Product Code
LWR
Device Class
Class III
Advisory Committee
Cardiovascular
FDA Decision
APPR Approved
PMA Supplement
S007

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Hancock Modified Orifice Bioprosthesis is a heart-valve, non-allograft tissue device. It is designed for use as a prosthetic heart valve to replace diseased or damaged native valves.

This device received FDA PMA approval (P790007) on March 6, 1980, and is manufactured by Medtronic Heart Valves in Santa Ana, CA. It is classified as a Class III device under product code LWR.

Other devices from Medtronic Heart Valves

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What type of device is the Hancock Modified Orifice Bioprosthesis?

    The Hancock Modified Orifice Bioprosthesis is a heart-valve, non-allograft tissue device, as defined in the specifications under generic_name and openfda device_name.

  • Who manufactures the Hancock Modified Orifice Bioprosthesis?

    The device is manufactured by Medtronic Heart Valves, as stated in both the MANUFACTURER and applicant fields in the device data.

  • What regulatory authorization does the Hancock Modified Orifice Bioprosthesis have?

    The device has FDA PMA authorization, with PMA number P790007 and decision date March 6, 1980, as shown in the AUTHORIZATIONS and pma_number fields.